Kangmei Pharmaceutical Co., Ltd. (SHSE: 600518)
Health Care · Pharmaceuticals · CN
CN¥1.36
-3.55% today · -35.5% 1Y
Kangmei Pharmaceutical Co., Ltd. (SHSE: 600518) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.80B and employs 5,492 people.
Over the last twelve months the share price has lost 35.5%, trading between 1.16 and 2.27.
Tweenvest scores Kangmei Pharmaceutical Co., Ltd. across four factors: quality 61/100, value 45/100, growth 12/100. Its strongest factor is quality.
600518 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.80B
- Revenue (TTM)
- $729.65M
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.49
- 52-week high
- CN¥2.27
- 52-week low
- CN¥1.16
- Avg volume (3M)
- —
- Shares outstanding
- 13.83B
- Employees
- 5,492
- Next earnings
- —
About Kangmei Pharmaceutical Co., Ltd.
Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is based in Shenzhen, China.
- ISIN
- CNE0000017M1
- Founded
- 1997
- Listed since
- Mar 19, 2001
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.